Sign In
Buy ABT
$90.53
+2.76 (+3.14%)
At Close: Jun 23, 2026
Abbott's (ABT) Q4 Earnings and Revenues Beat Estimates
12:17pm, Wednesday, 26'th Jan 2022
Abbott's (ABT) COVID-19 testing-related sales in Q4 increased on demand for BinaxNOW, Panbio and ID NOW rapid testing platforms.
Worldwide Filgrastim Industry to 2030 - Increase in Player-adopted Strategies Presents Opportunities - ResearchAndMarkets.com
11:03am, Wednesday, 26'th Jan 2022 Kwhen FinanceStocks Gain as Tech Rallies and Investors Await Fed Rate Decision
10:25am, Wednesday, 26'th Jan 2022
U.S. stocks are moving higher, led by tech, after another volatile trading day ahead of a Fed announcement about the future of monetary policy.
Abbott (ABT) Q4 Earnings and Revenues Surpass Estimates
09:59am, Wednesday, 26'th Jan 2022
Abbott (ABT) delivered earnings and revenue surprises of 11.86% and 8.52%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
Abbott Beats Earnings Expectations. The Stock is Down.
09:32am, Wednesday, 26'th Jan 2022
Shares of the maker of a leading Covid-19 at-home antigen test were down slightly in premarket trading Wednesday.
Abbott Posts $2.3B In COVID-19 Test Sales In Q4; Issues FY22 Outlook
08:39am, Wednesday, 26'th Jan 2022
Abbott Laboratories (NYSE: ABT) has reported Q4 FY21 adjusted EPS of $1.32, down from $1.45 a year ago but better than the consensus of $1.21. Q4 sales of $11.5 billion increased 7.2% on a reported
Abbott sold $2.3 billion in COVID-19 tests in the fourth quarter
08:05am, Wednesday, 26'th Jan 2022
Shares of Abbott Laboratories ABT, -0.44% were down 0.8% in premarket trading on Wednesday. The company beat expectations for both earnings and revenue in the fourth quarter, bolstered by more than $2
S&P 500 Corrects Ahead Of Fed Meeting: Let's Check The Technicals
04:10pm, Tuesday, 25'th Jan 2022
It's been a crazy start to what is expected to be the most pivotal week of Q1 market action.
Abbott Laboratories Can be a Port in the Market Storm
12:46pm, Tuesday, 25'th Jan 2022
First the bad news. Abbott Laboratories (NYSE:ABT) reports earnings tomorrow and there is growing sentiment that it will miss on either the top line or bottom line or both.
Will Abbott Stock Rise After Its Q4 Results?
06:00am, Tuesday, 25'th Jan 2022
Abbott is scheduled to report its Q4 2021 results on Wednesday, January 26, and we expect it to be below the consensus estimates. A rise in Covid-19 cases in Q4 due to the spread of the Omicron varian
Earnings Previews: Abbott Labs, AT&T, Boeing, Freeport-McMoRan
06:38pm, Monday, 24'th Jan 2022 24/7 Wall street
Here is a preview of four earnings reports due out before markets open on Wednesday.
Earnings Previews: Abbott Labs, AT&T, Boeing, Freeport-McMoRan
01:38pm, Monday, 24'th Jan 2022
We have well and truly arrived at the December-quarter earnings reporting season. Hundreds of results are due out this week, including those from the two largest U.S.
Abbott Laboratories Inc.'s ABT, -3.59% stock hit a 10-year high of $141.46 on Dec. 27 at the same time that people across the U.S. were scrambling to find COVID-19 tests due to the rapidly spreading o
Is a Surprise Coming for Abbott (ABT) This Earnings Season?
10:04am, Monday, 24'th Jan 2022
Abbott (ABT) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
2 Healthcare Stocks You Can Buy and Hold for the Next Decade
07:57am, Saturday, 22'nd Jan 2022
Both of these healthcare stalwarts offer dividends and double-digit revenue growth
